- sales@expolake.com
- +1-469-567-9589
Access a verified, campaign-ready database of oncology professionals, pharmaceutical executives, clinical researchers, biotech leaders, and healthcare decision-makers attending and exhibiting at the 2026 ASCO Annual Meeting in Chicago. With 40,000 plus attendees and 500 plus exhibiting organizations gathered at McCormick Place, ASCO 2026 represents the single highest concentration of oncology buyers, researchers, and clinical leaders on the global calendar.
Whether you are looking to schedule pre-event meetings, run targeted email campaigns, or expand your presence in the oncology and life sciences market, the ExpoLake ASCO 2026 contact list gives you the accurate, segmented data your team needs to reach the right people at the right time.
Verified Attendees
Exhibiting Companies
Accuracy
Delivery Time
Verification Layers
The ASCO Annual Meeting is the world’s largest oncology conference, organized by the American Society of Clinical Oncology. The 2026 edition runs May 29 to June 2 at McCormick Place in Chicago, welcoming professionals from 100+ countries for five days of groundbreaking science and high-value networking.
The 2026 theme, “The Science and Practice of Translation: Improving Cancer Outcomes Worldwide,” reflects ASCO’s focus on closing the gap between laboratory discovery and real-world patient impact. Presided over by Dr. Eric Small, the program features 200+ sessions, 450+ oral abstracts, and 2,700+ poster presentations.
The meeting draws 500+ exhibiting organizations including major pharma companies, biotech innovators, diagnostics firms, CROs, and medtech providers. For businesses targeting oncology and life sciences, there is no denser concentration of qualified decision-makers anywhere on the calendar.
500+ organizations across oncology, pharma, diagnostics, and life sciences occupy the exhibit floor at McCormick Place.
Global pharma and biotech firms presenting oncology drugs, immunotherapies, targeted therapies, and late-stage pipeline compounds to oncologists, KOLs, and hospital formulary committees.
Companies offering next-generation sequencing platforms, liquid biopsy tools, companion diagnostics, biomarker panels, and genomic profiling solutions for precision oncology.
CROs specializing in oncology trial design, patient enrollment, data management, regulatory submission support, and real-world evidence generation for pharma sponsors.
Providers of radiation therapy systems, robotic surgical platforms, oncology infusion technology, and treatment delivery equipment used across hospital cancer care settings.
Vendors delivering AI-powered diagnostics, electronic oncology records, patient data analytics, real-world data solutions, and clinical decision support software.
Organizations providing market access advisory, HEOR, payer strategy, medical communications, reimbursement support, and regulatory consulting to oncology developers.
Board-certified medical, surgical, and radiation oncologists from academic cancer centers, community practices, and NCI-designated cancer hospitals evaluating new treatments and clinical care protocols.
Principal investigators, research directors, and bench scientists leading phase I to phase III oncology trials and translational research programs at academic and private institutions.
C-suite leaders, VP-level decision-makers, medical affairs directors, and business development heads from pharmaceutical and biotech organizations responsible for drug development strategy.
Hospital CEOs, oncology program directors, CMOs, and insurance/payer medical directors who oversee cancer care delivery, formulary management, and reimbursement policy at health systems.
Trial coordinators, regulatory affairs managers, clinical operations leads, IRB specialists, and drug safety officers managing protocol oversight, FDA/EMA submissions, and compliance.
Oncology certified nurses, nurse practitioners, physician assistants, pharmacists, and supportive care specialists attending for CME, protocol updates, and clinical practice guidance.
The ASCO 2026 contact database includes 20+ structured contact, firmographic, and organizational data fields — built for precise segmentation and role-based targeting across oncology, pharma, biotech, and clinical research organizations
Each record provides insight into the individual contact, their functional responsibility, and the organization they represent, enabling outreach that goes beyond basic contact identifiers.
Core Data Fields in Our ASCO 2026 Attendees and Exhibitors List
These 20+ fields can be combined to create targeted oncology segments filtered by specialty, job function, institution type, and region. A reliable ASCO 2026 list ensures every campaign is built on accuracy and genuine purchase intent.
Engage verified oncologists, pharma executives, clinical researchers, hospital administrators, and procurement decision-makers who are actively attending or exhibiting at ASCO 2026, not passive records pulled from a generic database.
Every contact record is validated through email ping checks, domain verification, and cross-referencing against official ASCO exhibitor filings and LinkedIn profiles before delivery. Bounced records are replaced at no extra cost.
Use the ASCO 2026 contact list for email campaigns, LinkedIn ABM, phone prospecting, pre-event appointment scheduling, and targeted follow-ups that convert oncology conference leads into long-term business opportunities.
Each listing includes verified job titles, oncology specialty, organization type, seniority level, company size, and direct contact details, giving your team the context needed for personalized, high-conversion outreach from day one.
Segment contacts by oncology sub-specialty, institution type (academic, community, pharma, CRO), geographic region, company size, or seniority level for campaigns that speak directly to the specific buyer you are targeting.
All data is sourced using consent-first workflows aligned with GDPR, CAN-SPAM, and CASL. Standard delivery in 3 to 5 business days in Excel or CSV format, compatible with Salesforce, HubSpot, Marketo, and all major CRM platforms.
Get verified attendee and exhibitor contact lists from past and upcoming event editions worldwide. ExpoLake delivers accurate, segmented B2B contact data covering key decision-makers and exhibiting companies, so your outreach always reaches the right person at the right time.
Before making your investment, request a complimentary preview of the ExpoLake ASCO Annual Meeting 2026 database. This verified contact list covers attendees and exhibitors across oncology, pharmaceutical, biotech, and clinical research sectors, giving your team direct access to the decision-makers who matter most at the world’s largest cancer conference.
Every record is validated, segmented, and delivered ready for email, LinkedIn, phone prospecting, and direct sales campaigns. See the data quality for yourself before committing. Request a complimentary sample of the ASCO Annual Meeting 2026 attendees and exhibitors list today.
Skip the gatekeepers. The ASCO 2026 database puts you in front of verified medical oncologists, pharmaceutical executives, clinical trial directors, and hospital procurement leads who have the authority to make purchasing and partnership decisions.
Get ahead of the competition by reaching ASCO 2026 attendees and exhibitors before the event begins. Schedule booth appointments, send targeted email sequences, and warm up prospects weeks before McCormick Place opens its doors.
ASCO attendees are not passive contacts. They are active market participants who have invested time and budget to attend a specific oncology event, making them significantly warmer and more responsive than any cold outreach list.
Use the ASCO 2026 database to break into new verticals within oncology and life sciences, whether that is diagnostics, immunotherapy, clinical research, medtech, or hospital administration, with contacts segmented precisely for your target market.
Do not let conference momentum fade. Use verified ASCO 2026 contact data to follow up with attendees and exhibitors after the event closes, keeping your brand top of mind while competitors scramble to find contact details.
Every dollar spent exhibiting or sponsoring at ASCO 2026 goes further when paired with a verified contact database. Targeted pre-event and post-event outreach multiplies the return on your conference investment across every channel you run.
Every contact in the ExpoLake database goes through a structured, multi-step sourcing and verification process before it reaches your team. Here is how we build data you can trust.
Contacts are gathered from trade shows, global directories, e-books, newsletters, and digital publications spanning dozens of industries and regions.
Machine learning fills missing fields, appends firmographic data, and segments contacts by industry, role, company size, and intent signals — automatically.
Every record is cross-checked against our master database and validated via social platforms, public registries, and news sources to confirm authenticity.
Anomalies, duplicates, and stale entries are flagged using statistical models and eliminated. A final manual audit ensures the highest standard of data quality.
A/B-tested opt-in email sequences are deployed to capture and confirm explicit consent, fully aligned with GDPR, CAN-SPAM, and CASL compliance frameworks.
A final tele-verification call confirms all data fields. Only fully validated, consented records are released to the client — clean, compliant, and ready to use.
Each record includes full name, job title, verified business email, direct phone number, company name, organization type, oncology specialty, seniority level, location, and LinkedIn URL. Delivered in Excel or CSV format compatible with all major CRM platforms.
ExpoLake maintains a 95% accuracy standard. Every record is validated through email verification, domain checks, and LinkedIn cross-referencing. Bounced records are replaced at no additional charge.
Yes. You can request the exhibitors list, attendees list, or a combined database. Custom segmentation by organization type, specialty, or geography is available at no extra cost.
The database covers medical oncologists, pharma executives, clinical trial directors, hospital procurement managers, biotech leaders, CRO heads, and healthcare IT decision-makers attending or exhibiting at McCormick Place.
Yes. All data is built using consent-first, opt-in-aligned sourcing workflows aligned with GDPR, CAN-SPAM, and CASL requirements.
Yes. Use the database to schedule booth appointments, run pre-event email sequences, and launch LinkedIn campaigns targeting verified attendees before and after the conference.
Standard delivery is 2 to 4 business days. Rush delivery in 24 to 48 hours is available. A complimentary sample can be shared within one business day on request.
